Sugammadex Sodium Solution
Product Images NDC 82449-241

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sugammadex Sodium (NDC 82449-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Steriscience Specialties Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prefilled Syringe Blister Foil Label (Carton Label 2ml)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution by Steriscience Specialties Private Limited. The label indicates single-dose prefilled syringes containing 10 x 2 mL. It includes usage instructions, barcodes, and layout markings for the carton.*

FDA Label Image

Prefilled Syringe Blister Foil Label-5 mL (Carton Label 5ml)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use. The carton label indicates the product is supplied as 10 single-dose prefilled syringes of 5 mL each. The labeler is Steriscience Specialties Private Limited. The design features orange and white colors with dosing and usage information.*

FDA Label Image

Image Description (Figure 1)

A Kaplan-Meier curve chart showing the cumulative recovery rate over time in minutes. It compares recovery times between sugammadex 2 mg/kg (solid line) and neostigmine 0.05 mg/kg (dashed line) after rocuronium administration. Sugammadex shows a faster recovery with a median time of 1.4 minutes versus 21.5 minutes for neostigmine, based on 48 subjects in each group.*

FDA Label Image

Image Description (Figure 2)

A cumulative recovery rate graph comparing recovery times for sugammadex 2 mg/kg and neostigmine 0.05 mg/kg in patients administered with vecuronium. The x-axis represents time to recovery in minutes, and the y-axis shows cumulative recovery rate. The graph indicates faster recovery with sugammadex than neostigmine, based on median recovery times.*

FDA Label Image

Carton Label (Pfs Foil Label 2ml)

Suggamadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use, packaged as a 2 mL single-dose prefilled syringe. The label indicates it is manufactured by Steriscience Specialties Private Limited. Storage and usage instructions, lot number, expiration date, and barcode are also visible.*

FDA Label Image

Carton Label-5 mL (Pfs Foil Label 5ml)

SUGAMMADEX SODIUM 500 mg/5 mL solution for intravenous use in a 5 mL single-dose prefilled syringe. The label includes storage instructions and is manufactured by Steriscience Specialties Private Limited, India. The product is identified as Rx only and displays the brand name Sugammadex Injection.*

FDA Label Image

Prefilled Syringe Label (Pfs Label 2ml)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) intravenous solution in a 2 mL single-dose prefilled syringe. The label includes dosing information, storage instructions (25°C, protect from light), manufacturer details (OneSource Specialty Pharma Limited, made in India), and is labeled for prescription use only. The label also features a barcode and batch-related fields.*

FDA Label Image

Prefilled Syringe Label-5 mL (Pfs Label 5ml)

Label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use. The label states it is a 5 mL single-dose prefilled syringe, stored at 25°C (77°F), protected from light, with instructions to discard unused portion. Manufactured by OneSource Specialty Pharma Limited, India, and labeled by Steriscience Specialties Private Limited. Includes NDC 82499-242-01 barcode and prescription only indication.*

FDA Label Image

Structure-1 (Structure 1)

Chemical structure diagram of the active ingredient Sugammadex Sodium, showing its molecular arrangement and sodium carboxylate groups.*

FDA Label Image

Structure-2 (Structure 2)

Chemical structure of sugammadex sodium, a complex cyclic molecule shown with multiple sodium carboxylate groups and sugar-like rings containing oxygen and sulfur atoms.*

FDA Label Image

Image Description (Syringe Image 1)

An instructional diagram of a syringe showing the removal of the syringe tip cap and labeling the plunger rod with a note not to remove it.*

FDA Label Image

Image Description (Syringe Image 2)

An instructional diagram depicting the steps to attach or secure a component to a syringe. One illustration shows a hand twisting a part on top of a syringe plunger. Another section labels parts A, B, and C of a plastic device, likely a syringe adapter or connector, showing details of its components.*

FDA Label Image

Image Description (Syringe Image 3)

An instructional diagram showing the assembly or connection of a medical component. The left side depicts a hand pulling upward on a small cap or stopper from a syringe, indicated by an upward arrow. The right side shows a close-up of a clear plastic connector with labeled parts A, B, and C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.